—A recent analysis showed that health concerns, rather than costs, influenced treatment strategies in commercially insured men with prostate cancer. Among men with newly diagnosed prostate cancer, ...
From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret value.
Rucaparib vs docetaxel (DTX) or second-generation androgen receptor pathway inhibitor (ARPI) therapy for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with BRCA mutations ...
Prostate cancer survivors and campaigners have urged the Government not to scrap plans for a life-saving national screening programme. Prostate cancer is the last major cancer without such a ...
HUNTSVILLE, Ala. (WHNT) — A new law is taking effect in Alabama next year that will make prostate cancer screenings more affordable. The law will require insurance companies to fully cover prostate ...
MONTGOMERY, Ala. (WSFA) - Several bills moving through the Alabama legislature aim to promote early detection for two of the most common cancer diagnoses by keeping money in the pockets of insured ...
Efficacy and safety of mevrometostat (M) in combination with enzalutamide (E) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Data from a phase 1 study. Results of a ...
New Publication Shows PROSTOX™ ultra Test Delivers Significant Health System Cost Savings and Quality-of-Life Gains for Prostate Cancer Patients Undergoing Radiation Therapy MiraDx, a molecular ...
In partnership with Winship Cancer Institute of Emory University, Cobb County Public Library will host the Winship Mobile ...